Nebenwirkungen · Foclivia
Foclivia suspension for injection in pre-filled syringe Pandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) · Abschnitt 4.8 · PDF-Seite 6
HOS-212746 · Präparat HOS-154968
Gastrointestinal Nausea2, disorders Diarrhoea2, Vomiting2 Skin and subcutaneous Sweating2, Urticaria tissue disorders Unusual sweating1 Musculoskeletal and Myalgia Arthralgia connective tissue disorders General disorders and Injection site Injection site administration site swelling, hemorrhage conditions Injection site pain, Injection site tenderness1, Injection site induration, Injection site redness, Injection site ecchymosis2, Fatigue, Chills/Shiverin g, Malaise, Sleepiness1, Irritability1, Unusual crying1, Fever3 1 Reported only in paediatric subjects 6-35 months 2 Reported as Common in adults (18-60 years) and elderly (≥ 61 years) 3 Reported as Very common only in paediatric subjects 6 months-8 years. Reported as Common in adolescents and adults 9-
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-06-16T09:31:00Z · SHA-256 03d4abeebc6353c3f61b12133eba34d04f4ddb38a99b9dd429b813672ea12588 · Passage 4fa62fdf9371242d916ad6595ca09c97e85e0d13fe196bde68ba6b07554d66e6 · Zeichen 3622–5348 im Abschnitt